Isoflurane inhibits Angiotensin II-induced vasoconstriction by attenuating the increase in intracellular Ca2+, a mechanism distinct from sevoflurane which inhibits PKC phosphorylation.
Answers are grounded in this paper and cite their sources.
May attenuate Ang II vasoconstriction via Ca2+ in animal vessels; leaves open translation to clinical anesthesia or distinction from sevoflurane.
In Brief BACKGROUND: Angiotensin II (Ang II)-induced vascular contraction is mediated both by a Ca2+-mediated signaling pathway and a Ca2+ sensitization mechanism. We recently demonstrated that sevoflurane inhibits the contractile response to Ang II, mainly by inhibiting protein kinase C (PKC) phosphorylation that regulates myofilament Ca2+ sensitivity, without significant alteration of intracellular Ca2+ concentration ([Ca2+]i) in rat aortic smooth muscle. The current study was designed to determine the mechanisms by which isoflurane inhibits Ang II-induced contraction of rat aortic smooth muscle. METHODS: The effects of isoflurane on vasoconstriction, increase in [Ca2+]i, and phosphorylation of PKC in response to Ang II (10−7 M) were investigated, using an isometric force transducer, a fluorometer, and Western blotting, respectively. RESULTS: Ang II elicited a transient contraction of rat aortic smooth muscle that was associated with an increase in [Ca2+]i and PKC phosphorylation. Isoflurane (1.2%–3.5%) inhibited Ang II-induced contraction of rat aortic smooth muscle in a concentration-dependent manner (P < 0.05 at 1.2%, P < 0.01 at 2.3% and 3.5% isoflurane, n = 6). Isoflurane also inhibited elevation of [Ca2+]i in response to Ang II (P < 0.01 at 2.3% and 3.5% isoflurane, n = 6), but failed to affect Ang II-induced phosphorylation of PKC at concentrations up to 3.5% (n = 7). CONCLUSION: These results suggest that, unlike sevoflurane, the inhibitory effect of isoflurane on Ang II-induced contraction is mainly mediated by attenuation of the Ca2+-mediated signaling pathway. IMPLICATIONS: Isoflurane, at clinically relevant concentrations, inhibits angiotensin II-induced vasoconstriction, but by a mechanism that differs from that of sevoflurane. Unlike sevoflurane, the inhibitory effect of isoflurane on vascular contraction is mainly mediated by an attenuation of the increase in intracellular Ca2+ in response to angiotensin II.
No takes yet. Share an insight, caveat, or question.
Ishikawa et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: